|
| 37318058 | PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2023 |
| 35307742 | Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study. | Neuro Oncol | 2022 |
| 35703183 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2022 |
| 35820112 | Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321). | J Clin Oncol | 2022 |
| 35945463 | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Acta Neuropathol | 2022 |
| 35852795 | Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 |
| 32966846 | Rate of radiation-induced microbleed formation on 7T MRI relates to cognitive impairment in young patients treated with radiation therapy for a brain tumor. | Radiother Oncol | 2021 |
| 33631016 | A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2021 |
| 31104347 | High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis. | Brain Pathol | 2020 |
| 32139107 | Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. | Ophthalmology | 2020 |
| 32303840 | Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. | Acta Neuropathol | 2020 |
| 32157385 | Gliomas arising in the setting of Li-Fraumeni syndrome stratify into two molecular subgroups with divergent clinicopathologic features. | Acta Neuropathol | 2020 |
| 32817593 | Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma. | J Clin Invest | 2020 |
| 32859279 | Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. | Acta Neuropathol Commun | 2020 |
| 30877433 | Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. | Acta Neuropathol | 2019 |
| 30196423 | The genetic landscape of gliomas arising after therapeutic radiation. | Acta Neuropathol | 2019 |
| 30051528 | The genetic landscape of anaplastic pleomorphic xanthoastrocytoma. | Brain Pathol | 2019 |
| 31515627 | Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. | Acta Neuropathol | 2019 |
| 30861105 | A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium. | Int J Cancer | 2019 |
| 31453017 | Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial. | Global Advances In Health and Medicine | 2019 |
| 30675475 | The University of California, San Francisco Documentation System for Retinoblastoma: Preparing to Improve Staging Methods for This Disease. | Ocular Oncology and Pathology | 2019 |
| 31151904 | Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. | Lancet Oncol | 2019 |
| 29575995 | Large Vessel Arteriopathy After Cranial Radiation Therapy in Pediatric Brain Tumor Survivors. | J Child Neurol | 2018 |
| 30402262 | Early detection of recurrent medulloblastoma: the critical role of diffusion-weighted imaging. | Neurooncol Pract | 2018 |
| 29880043 | The genetic landscape of ganglioglioma. | Acta Neuropathol Commun | 2018 |
| 30206764 | Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience. | J Neurooncol | 2018 |
| 30231927 | Oligodendrogliomas, IDH-mutant and 1p/19q-codeleted, arising during teenage years often lack TERT promoter mutation that is typical of their adult counterparts. | Acta Neuropathol Commun | 2018 |
| 29435664 | Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation. | Acta Neuropathol | 2018 |
| 29741745 | Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2018 |
| 27778212 | Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients. | J Neurooncol | 2017 |
| 28453743 | Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. | Neuro Oncol | 2017 |
| 28339824 | A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. | Neuro Oncol | 2017 |
| 27540084 | Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. | Neuro Oncol | 2016 |
| 26251821 | Metastatic Diffuse Intrinsic Pontine Glioma to the Peritoneal Cavity Via Ventriculoperitoneal Shunt: Case Report and Literature Review. | Journal of Neurological Surgery Reports | 2015 |
| 25407389 | Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study. | J Neurooncol | 2015 |
| 25431212 | A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study. | Neuro Oncol | 2015 |
| 26188774 | A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors. | Childs Nerv Syst | 2015 |
| 25189788 | Pure germinomas of the central nervous system: treatment strategies and outcomes. | J Neurooncol | 2014 |
| 24311632 | Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. | Neuro Oncol | 2014 |
| 23666401 | Feasibility, safety, and indications for surgical biopsy of intrinsic brainstem tumors in children. | Childs Nerv Syst | 2013 |
| 23818751 | Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution. | Clinical Ophthalmology | 2013 |
| 24104527 | Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022). | Cancer | 2013 |
| 23592571 | Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas. | Neuro Oncol | 2013 |
| 21826561 | Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. | J Neurooncol | 2012 |
| 22350375 | The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. | J Neurooncol | 2012 |
| 22790443 | Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). | J Neurooncol | 2012 |
| 22983601 | Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. | J Neurooncol | 2012 |
| 22231932 | An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. | J Neurooncol | 2012 |
| 21495172 | Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies. | Am J Med Genet C Semin Med Genet | 2011 |
| 21339191 | Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas. | Neuro Oncol | 2011 |